President and CEO

Inhibikase Therapeutics Announces Appointment of David McIntyre as Chief Financial Officer

Braeburn gets FDA approval for opioid use disorder drug after more than 4-year battle

FDA clears Braeburn's long-acting Brixadi to treat opioid use disorder

Camurus announces that Braeburn resubmits NDA for Brixadi™ in the US

Director, Patient Marketing

Braeburn is dedicated to transforming the management of opioid use disorder (OUD) and is seeking a Director of Patient Marketing to lead patient-focused marketing strategies. This role involves developing and executing campaigns that empower patients, reduce treatment barriers, and ensure optimal patient outcomes while collaborating cross-functionally and managing a direct report.

Sign up with Google

Sign in with Google